🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial

Global - Asia Archived • November 3, 2026 •
Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial
An anticancer drug developed by Sichuan Biokin Pharmaceutical took centre stage in a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Congress in Madrid last week.
Researchers said the drug, iza-bren, showed a significant advantage over platinum-based chemotherapy in a phase 3 randomised, double-blind clinical trial conducted at 73 hospitals in China and involving 432 patients with advanced lung cancer.
The median progression-free survival (PFS) – the length of...
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
"Cardamom Spices and more to satisfy the tastebuds 100g $14.94"
"Adventure is where you chose to go."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"We build AI or anything ICST"